U.S. market Closed. Opens in 1 day 10 hours 27 minutes

ENTA | Enanta Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-30
Revenue67.64M79.20M86.16M97.07M122.47M205.20M206.62M102.81M88.27M160.88M47.74M32.05M41.71M41.88M22.76M
Cost of RevenueN/AN/A2.97MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit67.64M79.20M83.19M97.07M122.47M205.20M206.62M102.81M88.27M160.88M47.74M32.05M41.71M41.88M22.76M
Operating Expenses189.33M216.41M210.00M206.65M164.11M168.46M118.30M78.20M57.43M36.73M28.76M23.02M20.42M16.58M15.82M
Selling, General & Admin57.85M52.89M45.48M32.54M27.36M26.25M23.44M20.75M16.97M13.54M10.02M6.18M5.30M5.04M6.11M
Research & Development131.48M163.52M164.52M174.11M136.76M142.21M94.86M57.45M40.46M23.19M18.74M16.84M15.12M11.55M9.72M
Other Operating ExpensesN/AN/A83.00K1.99M6.62M8.82M4.79M2.33M1.72M1.31M283.00K598.00KN/A5.04M309.00K
Operating Income-121.69M-137.21M-123.84M-109.57M-41.64M36.74M88.33M24.61M30.84M124.15M18.98M9.03M21.29M25.30M6.94M
Other Expenses / Income3.90M6.21M1.66M1.99M6.62M8.82M4.79M2.33M1.72M1.31M283.00K598.00K110.00K-1.99M805.00K
Before Tax Income-117.79M-131.00M-122.19M-107.58M-35.02M45.56M93.12M26.95M32.56M125.45M19.27M9.63M21.40M23.31M7.75M
Income Tax Expenses-1.74M2.82M-433.00K-28.58M1.15M-826.00K21.16M9.24M10.89M46.46M-15.17M-221.00KN/A3.16M-157.00K
Net Income-116.05M-133.82M-121.75M-79.00M-36.17M46.38M71.96M17.71M21.67M78.99M34.44M9.63M21.40M23.31M7.90M
Interest Expenses10.94M5.15M1.57MN/AN/A8.82M4.85M40.00K45.00K8.00K18.00K31.00KN/A3.16MN/A
Basic Shares Outstanding21.16M20.97M20.60M20.17M19.94M19.58M20.65M19.07M18.93M18.67M18.36M9.79M1.16M1.16M12.75M
Diluted Shares Outstanding21.16M20.97M20.60M20.17M19.94M20.97M20.65M19.41M19.22M19.30M19.18M9.79M2.64M2.64M14.13M
EBITDA-104.51M-123.48M-119.22M-104.25M-37.99M40.00M90.85M26.75M32.50M124.79M19.34M9.25M21.57M26.97M8.30M
EBITDA Margin-154.52%-155.90%-138.36%-107.39%-31.02%19.49%43.97%26.02%36.82%77.57%40.50%28.86%51.72%64.40%36.46%
EBIT-106.85M-125.85M-120.61M-107.58M-35.02M54.38M97.97M26.99M32.60M125.46M19.29M9.44M21.40M29.63M7.75M
EBIT Margin-157.98%-158.89%-139.99%-110.82%-28.59%26.50%47.42%26.25%36.94%77.99%40.40%29.44%51.31%70.75%34.03%
Financial Year End2024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙